We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Jan. 20, 2025 SAN DIEGO, Jan. 20, 2025 /PRNewswire/ --Β Avidity Biosciences, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.66 | 5.9413027917 | 27.94 | 31.3 | 27.53 | 1318687 | 29.47162504 | CS |
4 | -1.3 | -4.2071197411 | 30.9 | 32.5 | 26.74 | 1315382 | 29.46500565 | CS |
12 | -13.49 | -31.3065676491 | 43.09 | 56 | 26.74 | 1284084 | 36.76085845 | CS |
26 | -16.5 | -35.7917570499 | 46.1 | 56 | 26.74 | 1272560 | 41.07872231 | CS |
52 | 19.03 | 180.037842952 | 10.57 | 56 | 9.9336 | 1309337 | 34.65245269 | CS |
156 | 15.44 | 109.039548023 | 14.16 | 56 | 4.825 | 1055033 | 22.46502066 | CS |
260 | 10.95 | 58.7131367292 | 18.65 | 56 | 4.825 | 775193 | 22.76580208 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions